FULGENT GENETICS, INC. Operating Income
FULGENT GENETICS, INC. (FLGT) reported Operating Income of -$36.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-30
- FULGENT GENETICS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$36.07M.
- FULGENT GENETICS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$34.62M.
- FULGENT GENETICS, INC. operating income (loss) for the quarter ending 2025-12-31 was -$36.24M.
- FULGENT GENETICS, INC. operating income (loss) for the quarter ending 2025-09-30 was -$15.35M.
- FULGENT GENETICS, INC. operating income (loss) for fiscal 2025 was -$91.10M.
- FULGENT GENETICS, INC. operating income (loss) for fiscal 2024 was -$73.92M.
- FULGENT GENETICS, INC. operating income (loss) for fiscal 2023 was -$195.53M, a 209.52% decline from fiscal 2022.
- FULGENT GENETICS, INC. operating income (loss) for fiscal 2022 was $178.53M, a 73.59% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$36.07M 10-Q · filed 2026-07-30 | -$70.69M 10-Q · filed 2026-07-30 | -$106.93M derived: sum of 3 quarters · filed 2026-07-30 | -$122.28M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$34.62M 10-Q · filed 2026-05-01 | -$70.86M derived: sum of 2 quarters · filed 2026-05-01 | -$86.21M derived: sum of 3 quarters · filed 2026-05-01 | -$105.92M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$36.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$51.59M derived: sum of 2 quarters · filed 2026-02-27 | -$71.30M derived: sum of 3 quarters · filed 2026-07-30 | -$91.10M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$15.35M 10-Q · filed 2025-11-07 | -$35.06M derived: sum of 2 quarters · filed 2026-07-30 | -$54.86M 10-Q · filed 2025-11-07 | -$70.99M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$19.71M 10-Q · filed 2026-07-30 | -$39.51M 10-Q · filed 2026-07-30 | -$55.64M derived: sum of 3 quarters · filed 2026-07-30 | -$72.72M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$19.80M 10-Q · filed 2026-05-01 | -$35.93M derived: sum of 2 quarters · filed 2026-05-01 | -$53.01M derived: sum of 3 quarters · filed 2026-05-01 | -$71.92M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | -$16.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$33.21M derived: sum of 2 quarters · filed 2026-02-27 | -$52.12M derived: sum of 3 quarters · filed 2026-02-27 | -$73.92M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$17.08M 10-Q · filed 2025-11-07 | -$35.98M derived: sum of 2 quarters · filed 2025-11-07 | -$57.78M 10-Q · filed 2025-11-07 | -$208.90M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$18.91M 10-Q · filed 2025-08-01 | -$40.70M 10-Q · filed 2025-08-01 | -$191.82M derived: sum of 3 quarters · filed 2026-02-27 | -$191.61M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$21.80M 10-Q · filed 2025-05-02 | -$172.92M derived: sum of 2 quarters · filed 2026-02-27 | -$172.71M derived: sum of 3 quarters · filed 2026-02-27 | -$192.50M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$151.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$150.91M derived: sum of 2 quarters · filed 2026-02-27 | -$170.71M derived: sum of 3 quarters · filed 2026-02-27 | -$195.53M 10-K · filed 2026-02-27 |
| 2023-09-30 | $214.00K 10-Q · filed 2024-11-08 | -$19.58M derived: sum of 2 quarters · filed 2024-11-08 | -$44.41M 10-Q · filed 2024-11-08 | -$80.96M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$19.80M 10-Q · filed 2024-08-02 | -$44.62M 10-Q · filed 2024-08-02 | -$81.17M derived: sum of 3 quarters · filed 2024-08-02 | -$80.82M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | -$24.82M 10-Q · filed 2024-05-03 | -$61.38M derived: sum of 2 quarters · filed 2024-05-03 | -$61.02M derived: sum of 3 quarters · filed 2024-05-03 | -$48.23M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | -$36.55M 10-K · filed 2023-02-28 | -$36.20M derived: sum of 2 quarters · filed 2023-11-03 | -$23.41M derived: sum of 3 quarters · filed 2023-11-03 | $178.53M 10-K · filed 2025-02-28 |
| 2022-09-30 | $352.00K 10-Q · filed 2023-11-03 | $13.15M derived: sum of 2 quarters · filed 2023-11-03 | $215.08M 10-Q · filed 2023-11-03 | $365.94M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $12.79M 10-Q · filed 2023-08-04 | $214.73M 10-Q · filed 2023-08-04 | $365.59M derived: sum of 3 quarters · filed 2023-08-04 | $524.86M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $201.93M 10-Q · filed 2023-05-05 | $352.79M derived: sum of 2 quarters · filed 2023-05-05 | $512.07M derived: sum of 3 quarters · filed 2023-05-05 | $610.96M derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | $150.86M 10-K · filed 2023-02-28 | $310.13M derived: sum of 2 quarters · filed 2023-02-28 | $409.03M derived: sum of 3 quarters · filed 2023-02-28 | $675.95M 10-K · filed 2024-02-28 |
| 2021-09-30 | $159.27M 10-K · filed 2023-02-28 | $258.17M derived: sum of 2 quarters · filed 2023-02-28 | $525.09M 10-Q · filed 2022-11-07 | $751.00M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $98.90M 10-K · filed 2023-02-28 | $365.82M 10-Q · filed 2022-08-04 | $591.73M derived: sum of 3 quarters · filed 2023-02-28 | $655.25M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $266.92M 10-K · filed 2023-02-28 | $492.83M derived: sum of 2 quarters · filed 2023-02-28 | $556.35M derived: sum of 3 quarters · filed 2023-02-28 | $558.99M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $225.91M 10-K · filed 2022-02-28 | $289.43M derived: sum of 2 quarters · filed 2022-02-28 | $292.07M derived: sum of 3 quarters · filed 2022-02-28 | $290.16M 10-K · filed 2023-02-28 |
| 2020-09-30 | $63.52M 10-K · filed 2022-02-28 | $66.16M derived: sum of 2 quarters · filed 2022-02-28 | $64.25M 10-Q · filed 2021-11-09 | $63.84M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $2.64M 10-K · filed 2022-02-28 | $726.00K 10-Q · filed 2021-08-10 | $317.00K derived: sum of 3 quarters · filed 2022-02-28 | $1.83M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$1.91M 10-K · filed 2022-02-28 | -$2.32M derived: sum of 2 quarters · filed 2022-02-28 | -$814.00K derived: sum of 3 quarters · filed 2022-02-28 | -$519.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$409.00K 10-K · filed 2021-03-08 | $1.10M derived: sum of 2 quarters · filed 2021-03-08 | $1.40M derived: sum of 3 quarters · filed 2021-03-08 | -$428.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $1.51M 10-K · filed 2021-03-08 | $1.80M derived: sum of 2 quarters · filed 2021-03-08 | -$19.00K 10-Q · filed 2020-11-09 | -$1.05M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-06-30 | $295.00K 10-K · filed 2021-03-08 | -$1.53M 10-Q · filed 2020-08-05 | -$2.56M derived: sum of 3 quarters · filed 2021-03-08 | -$3.40M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-03-31 | -$1.82M 10-K · filed 2021-03-08 | -$2.85M derived: sum of 2 quarters · filed 2021-03-08 | -$3.70M derived: sum of 3 quarters · filed 2021-03-08 | -$4.70M derived: sum of 4 quarters · filed 2021-03-08 |
| 2018-12-31 | -$1.03M 10-K · filed 2020-03-13 | -$1.88M derived: sum of 2 quarters · filed 2020-03-13 | -$2.88M derived: sum of 3 quarters · filed 2020-03-13 | -$5.07M 10-K · filed 2020-03-13 |
| 2018-09-30 | -$846.00K 10-K · filed 2020-03-13 | -$1.85M derived: sum of 2 quarters · filed 2020-03-13 | -$4.04M 10-Q · filed 2019-11-08 | -$6.11M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | -$1.00M 10-K · filed 2020-03-13 | -$3.19M 10-Q · filed 2019-08-12 | -$5.26M derived: sum of 3 quarters · filed 2020-03-13 | -$6.75M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | -$2.19M 10-K · filed 2020-03-13 | -$4.26M derived: sum of 2 quarters · filed 2020-03-13 | -$5.75M derived: sum of 3 quarters · filed 2020-03-13 | -$5.89M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | -$2.07M 10-K · filed 2019-03-22 | -$3.55M derived: sum of 2 quarters · filed 2019-03-22 | -$3.70M derived: sum of 3 quarters · filed 2019-03-22 | -$3.48M 10-K · filed 2019-03-22 |
| 2017-09-30 | -$1.48M 10-K · filed 2019-03-22 | -$1.63M derived: sum of 2 quarters · filed 2019-03-22 | -$1.41M 10-Q · filed 2018-11-09 | -$153.00K derived: sum of 4 quarters · filed 2019-03-22 |
| 2017-06-30 | -$150.00K 10-K · filed 2019-03-22 | $69.00K 10-Q · filed 2018-08-13 | $1.33M derived: sum of 3 quarters · filed 2019-03-22 | $633.00K derived: sum of 4 quarters · filed 2019-03-22 |
| 2017-03-31 | $219.00K 10-K · filed 2019-03-22 | $1.48M derived: sum of 2 quarters · filed 2019-03-22 | $783.00K derived: sum of 3 quarters · filed 2019-03-22 | $1.75M derived: sum of 4 quarters · filed 2019-03-22 |
| 2016-12-31 | $1.26M 10-K · filed 2018-03-20 | $564.00K derived: sum of 2 quarters · filed 2018-03-20 | $1.53M derived: sum of 3 quarters · filed 2018-03-20 | $918.00K 10-K · filed 2018-03-20 |
| 2016-09-30 | -$695.00K 10-K · filed 2018-03-20 | $275.00K derived: sum of 2 quarters · filed 2018-03-20 | -$340.00K 10-Q · filed 2017-11-13 | -$7.68M derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-06-30 | $970.00K 10-K · filed 2018-03-20 | $355.00K 10-Q · filed 2017-08-14 | -$6.99M derived: sum of 3 quarters · filed 2018-03-20 | -$5.81M derived: sum of 4 quarters · filed 2018-03-20 |
| 2016-03-31 | -$615.00K 10-K · filed 2018-03-20 | -$7.96M derived: sum of 2 quarters · filed 2018-03-20 | -$6.78M derived: sum of 3 quarters · filed 2018-03-20 | -$6.03M derived: sum of 4 quarters · filed 2018-03-20 |
| 2015-12-31 | -$7.34M 10-K · filed 2017-03-17 | -$6.16M derived: sum of 2 quarters · filed 2017-03-17 | -$5.42M derived: sum of 3 quarters · filed 2017-03-17 | -$5.01M 10-K · filed 2017-03-17 |
| 2015-09-30 | $1.18M 10-K · filed 2017-03-17 | $1.93M derived: sum of 2 quarters · filed 2017-03-17 | $2.33M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $747.00K 10-K · filed 2017-03-17 | $1.15M derived: sum of 2 quarters · filed 2017-03-17 | ||
| 2015-03-31 | $405.00K 10-K · filed 2017-03-17 | |||
| 2014-12-31 | -$990.00K 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |